Concepedia

Author

Pablo Navarro

Hospital Clínico Universitario de ValenciaORCID

Also Known As

Cortes, Pierre-Yves, Joanna Wypych, M. Muñoz, Navarro, Pablo, P Navarro, P Navarro-Cortes, P. Navarro, P. Navarro- Cortés, P. Navarro-Cortes, PABLO NAVARRO

109

Publications

1.3K

Citations

17

H-Index

39

Concepts

All Affiliations

Hospital Clínico Universitario de ValenciaHospital Universitario de La PrincesaHospital Universitario Reina SofíaCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y DigestivasHospital Universitari i Politècnic La Fe
PN

About

Pablo Navarro is an author at Hospital Clínico Universitario de Valencia specializing in medicine, gastroenterology, and epidemiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

300

2

Gastroenterology

4

4

115

3

Public Health

3

3

98

4

Epidemiology

3

3

98

5

Microbiology

1

1

19

Pablo Navarro

×

21

Publications

1.1K

Citations

15

H-Index

YearCitations

Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis

Enrique de‐Madaria, James Buxbaum, Patrick Maisonneuve,

New England Journal of Medicine

2022

262

A prominent and conserved role for YY1 in Xist transcriptional activation

M. Makhlouf, Jean‐François Ouimette, Andrew J. Oldfield,

Nature Communications

2014

146

<i>Tsix</i>-mediated epigenetic switch of a CTCF-flanked region of the <i>Xist</i> promoter determines the <i>Xist</i> transcription program

Pablo Navarro, Damian R. Page, Philip Avner,

Genes & Development

2006

134

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

María Chaparro, Ana Garre, Andrea Núñez Ortiz,

Journal of Clinical Medicine

2021

92

The region 3′ to Xist mediates X chromosome counting and H3 Lys‐4 dimethylation within the Xist gene

Céline Morey, Pablo Navarro, Emmanuel Debrand,

The EMBO Journal

2004

76

Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry

Marisa Iborra, Belén Beltrán, A Fernández-Clotet,

Alimentary Pharmacology & Therapeutics

2019

70

Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry

Marisa Iborra, Belén Beltrán, A Fernández-Clotet,

Alimentary Pharmacology & Therapeutics

2020

65

Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study

Gionata Fiorino, Pablo Navarro, Pierre Ellul,

Clinical Gastroenterology and Hepatology

2016

48

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

Laurent Peyrin‐Biroulet, Jean‐François Rahier, Julien Kirchgesner,

Clinical Gastroenterology and Hepatology

2022

37

Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry

Fiorella Cañete, Míriam Mañosa, María José Casanova,

Inflammatory Bowel Diseases

2019

36

Page 1